Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
<strong>Objectives</strong> To investigate patient characteristics predictive of response to secukinumab in patients with psoriatic arthritis (PsA) with axial manifestations. <br><strong> Methods</strong> In a post-hoc analysis from the MAXIMISE trial (NCT02721966) in p...
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Journal article |
| Taal: | English |
| Gepubliceerd in: |
BMJ Publishing Group
2022
|